All In Biotech

Free tool

FAERS Monitor: Methotrexate Preservative Free

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 011719 or its brand name (Methotrexate Preservative Free, Methotrexate Sodium). Reports on generic versions are filed under their own applications.

Reports

487,627

Serious

358,960

74% of reports

Hospitalization

134,459

Death reported

38,300

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective93,085
  • rheumatoid arthritis42,801
  • arthralgia40,718
  • off label use40,573
  • pain39,635
  • fatigue33,027
  • nausea28,920
  • joint swelling24,995
  • drug intolerance24,515
  • condition aggravated23,993
  • headache23,450
  • rash22,590
  • diarrhoea20,904
  • pain in extremity20,026
  • drug hypersensitivity19,718

Reports by year received

View as table
YearReports
20045,891
20055,584
20065,149
20078,029
20089,257
20099,418
20109,834
201110,985
201215,617
201317,734
201417,445
201521,279
201625,472
201732,187
201843,779
201940,975
202046,026
202130,926
202234,807
202332,370
202427,844
202523,597
202613,413

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,566,532 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
rheumatoid arthritisSignal42,80125.525.2630,952
drug intoleranceSignal24,51514.314.1227,840
joint swellingSignal24,99511.010.9181,256
drug hypersensitivitySignal19,7184.84.753,423
arthralgiaSignal40,7184.64.5104,639
condition aggravatedSignal23,9933.63.642,307
drug ineffectiveSignal93,0853.23.2139,758
pain in extremitySignal20,0263.13.026,460
painSignal39,6352.92.947,745
rashSignal22,5902.32.316,120
off label useSignal40,5732.02.021,623
fatigue33,0271.91.813,210
headache23,4501.61.65,768
nausea28,9201.61.66,477
diarrhoea20,9041.41.42,488

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.